Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 4041-4046

  Comar, Manola ^a,c   Iannacone, Michelle R ^b   Casalicchio, Giorgia ^a   McKay Chopin, Sandrine ^b   Tommasino, Massimo ^b   Gheit, Tarik ^b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E7; VIRUS DNA;

ADULT; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DNA DETERMINATION; FEMALE; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS DETECTION; VIRUS LOAD;

ADULT; DNA, VIRAL; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

EID: 84869238636     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02105-12     Document Type: Article

References (42)

1. Arbyn M, et al. 2004. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J. Natl. Cancer Inst. 96:280-293. (Pubitemid 38256273)
2. Arbyn M, et al. 2009. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J. Cell. Mol. Med. 13:648-659.
3. Bosch FX, et al. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(Suppl 10):K1-K16.
4. Carozzi FM, et al. 2005. Reproducibility of HPV DNA testing by Hybrid Capture 2 in a screening setting. Am. J. Clin. Pathol. 124:716-721.
5. Castellsague X, et al. 2001. Human papillomavirus genotypes in rural Mozambique. Lancet 358:1429 -1430.
6. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. 2008. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study. J. Clin. Microbiol. 46:109-117.
7. Cento V, et al. 2012. Human papillomaviruses 53 and 66: clinical aspects and genetic analysis. Virus Res. 163:212-222.
8. Chaturvedi AK, et al. 2011. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J. Infect. Dis. 203:910-920.
9. Clavel C, et al. 2000. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn. Mol. Pathol. 9:145-150. (Pubitemid 30664126)
10. Cox JT. 2001. Management of atypical squamous cells of undetermined significance and low-grade squamous intra-epithelial lesion by human papillomavirus testing. Best Pract. Res. Clin. Obstet. Gynaecol. 15:715-741. (Pubitemid 33026196)
11. Cuschieri KS, et al. 2004. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J. Clin. Pathol. 57:68-72. (Pubitemid 38091314)
12. Fujinaga Y, et al. 1991. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J. Gen. Virol. 72(Pt 5):1039-1044.
13. Gallahan D, et al. 1989. Human papillomavirus type 53. J. Virol. 63:4911-4912. (Pubitemid 19257877)
14. Gheit T, et al. 2006. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J. Clin. Microbiol. 44:2025-2031. (Pubitemid 43902148)
15. IARC. 2011. A review of human carcinogens part B: biological agents. Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum. 100B:1-475.
16. Mejlhede N, Bonde J, Fomsgaard A. 2009. High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 117:108-114.
17. Mendez F, et al. 2005. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J. Infect. Dis. 192:1158-1165. (Pubitemid 41368414)
18. Molano M, et al. 2002. Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women. Br. J. Cancer 87:1417-1421. (Pubitemid 36044317)
19. Morin C, et al. 2000. Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear. Acta Cytol. 44:576-586. (Pubitemid 30640327)
20. Munoz N, et al. 2004. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer 111:278-285. (Pubitemid 38924707)
21. Pista A, Oliveira A, Verdasca N, Ribeiro F. 2011. Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women. Clin. Microbiol. Infect. 17:941-946.
22. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. 2007. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 195:1582-1589. (Pubitemid 46799215)
23. Poljak M, Brencic A, Seme K, Vince A, Marin IJ. 1999. Comparative evaluation of first- and second-generation Digene Hybrid Capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J. Clin. Microbiol. 37:796-797. (Pubitemid 29091309)
24. Poljak M, et al. 2011. Comparison of clinical and analytical performance of the Abbott RealTime high risk HPV test to the performance of Hybrid Capture 2 in population-based cervical cancer screening. J. Clin. Microbiol. 49:1721-1729.
25. Rassu M, et al. 2005. HPV genotype prevalence in cervical specimens with abnormal cytology: a report from north-east Italy. Scand. J. Infect. Dis. 37:476-481. (Pubitemid 41038519)
26. Rebolj M, Njor SH, Lynge E. 2012. Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review. Eur. J. Cancer Prev. 21:73-81.
27. Resnick RM, et al. 1990. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. 82:1477-1484. (Pubitemid 20281908)
28. Rousseau MC, et al. 2003. Predictors of cervical coinfection with multiplehuman papillomavirus types. Cancer Epidemiol. Biomarkers Prev. 12:1029-1037.
29. Safaeian M, et al. 2007. Comparison of the SPF10-LiPA system to the hybrid capture 2 assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J. Clin. Microbiol. 45:1447-1454. (Pubitemid 46762397)
30. Sasagawa T, et al. 2000. A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV). Virus Res. 67:127-139. (Pubitemid 30365166)
31. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907. (Pubitemid 47371147)
32. Schmitt M, et al. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512. (Pubitemid 43222244)
33. Schmitt M, et al. 2010. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J. Clin. Microbiol. 48:143-149.
34. Snijders PJ, et al. 1990. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J. Gen. Virol. 71:173-181. (Pubitemid 20046022)
35. Solomon D, et al. 2002. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114-2119. (Pubitemid 34437346)
36. Syrjanen K. 2008. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors. Eur. J. Gynaecol. Oncol. 29:205-221. (Pubitemid 351744480)
37. Thrall MJ, et al. 2010. High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up. Am. J. Clin. Pathol. 133:894-898.
38. Tieben LM, et al. 1993. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J. Virol. Methods 42:265-279.
39. van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers JM. 1990. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J. Clin. Microbiol. 28:2739 -2743.
40. van den Brule AJ, et al. 2002. GP5+/6+PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779 -787.
41. Walboomers JM, et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19. (Pubitemid 29406813)
42. Wright TC, Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2002. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120 -2129.